Vimarsana
Biggest News Aggregation in the World

John Corboy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from John Corboy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In John Corboy Today - Breaking & Trending Today

Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today - Vimarsana News

Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today

19.04.2024 - - Intranasal foralumab attenuated microglial activation in patients with non-active secondary progressive multiple sclerosis and progression independent of relapse (PIRA) -- Data presented in a platform session at the Annual Meeting of the American ... Seite 1

Stopping High-Efficacy MS Drugs Raises Relapse Risk for Older Patients - Vimarsana News

Stopping High-Efficacy MS Drugs Raises Relapse Risk for Older Patients

Discontinuing natalizumab and fingolimod carried highest risk

'We Feel Like We're Drowning': What We Heard This Week - Vimarsana News

'We Feel Like We're Drowning': What We Heard This Week

Quotable quotes heard by <em>MedPage Today</em>'s reporters

Clinical Challenges in MS: Addressing Radiologically Isolated Syndrome - Vimarsana News

Clinical Challenges in MS: Addressing Radiologically Isolated Syndrome

Is this earliest of stages a chance to intervene early, or too uncertain to treat?

Clinical Challenges: Determining When to Stop MS Therapy as Patients Age - Vimarsana News

Clinical Challenges: Determining When to Stop MS Therapy as Patients Age

DISCOMS trial has provided data to guide decisions, now it's all about individualized discussions